These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21350310)

  • 21. Evaluation of the Effects of Cultured Bone Marrow Mesenchymal Stem Cell Infusion on Hepatocarcinogenesis in Hepatocarcinogenic Mice With Liver Cirrhosis.
    Matsuura K; Takami T; Maeda M; Hisanaga T; Fujisawa K; Saeki I; Matsumoto T; Hidaka I; Yamamoto N; Sakaida I
    Transplant Proc; 2019 Apr; 51(3):925-935. PubMed ID: 30979485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice.
    Higashiyama R; Inagaki Y; Hong YY; Kushida M; Nakao S; Niioka M; Watanabe T; Okano H; Matsuzaki Y; Shiota G; Okazaki I
    Hepatology; 2007 Jan; 45(1):213-22. PubMed ID: 17187438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autologous bone marrow-derived mesenchymal stem cell transplantation promotes liver regeneration after portal vein embolization in cirrhotic rats.
    Li T; Zhu J; Ma K; Liu N; Feng K; Li X; Wang S; Bie P
    J Surg Res; 2013 Oct; 184(2):1161-73. PubMed ID: 23809154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression.
    Rabani V; Shahsavani M; Gharavi M; Piryaei A; Azhdari Z; Baharvand H
    Cell Biol Int; 2010 Apr; 34(6):601-5. PubMed ID: 20178458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of galectin-3 expression and liver fibrosis after cell therapy in a mouse model of cirrhosis.
    de Oliveira SA; de Freitas Souza BS; Sá Barreto EP; Kaneto CM; Neto HA; Azevedo CM; Guimarães ET; de Freitas LA; Ribeiro-Dos-Santos R; Soares MB
    Cytotherapy; 2012 Mar; 14(3):339-49. PubMed ID: 22149185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reevaluation of bone marrow-derived cells as a source for hepatocyte regeneration.
    Cantz T; Sharma AD; Jochheim-Richter A; Arseniev L; Klein C; Manns MP; Ott M
    Cell Transplant; 2004; 13(6):659-66. PubMed ID: 15648736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow cells ameliorate liver fibrosis and express albumin after transplantation in CCl₄-induced fibrotic liver.
    Ali G; Masoud MS
    Saudi J Gastroenterol; 2012; 18(4):263-7. PubMed ID: 22824770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis.
    Mohamadnejad M; Alimoghaddam K; Mohyeddin-Bonab M; Bagheri M; Bashtar M; Ghanaati H; Baharvand H; Ghavamzadeh A; Malekzadeh R
    Arch Iran Med; 2007 Oct; 10(4):459-66. PubMed ID: 17903050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice.
    Sakaida I; Terai S; Yamamoto N; Aoyama K; Ishikawa T; Nishina H; Okita K
    Hepatology; 2004 Dec; 40(6):1304-11. PubMed ID: 15565662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autologous mobilized peripheral blood CD34(+) cell infusion in non-viral decompensated liver cirrhosis.
    Sharma M; Rao PN; Sasikala M; Kuncharam MR; Reddy C; Gokak V; Raju B; Singh JR; Nag P; Nageshwar Reddy D
    World J Gastroenterol; 2015 Jun; 21(23):7264-71. PubMed ID: 26109814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance and therapeutic potential of endothelial progenitor cell transplantation in a cirrhotic liver rat model.
    Nakamura T; Torimura T; Sakamoto M; Hashimoto O; Taniguchi E; Inoue K; Sakata R; Kumashiro R; Murohara T; Ueno T; Sata M
    Gastroenterology; 2007 Jul; 133(1):91-107.e1. PubMed ID: 17631135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of a transjugular intrahepatic portosystemic shunt combined with autologous bone marrow cell infusion in patients with decompensated liver cirrhosis: an exploratory study.
    Huang M; Feng Z; Ji D; Cao Y; Shi X; Chen P; Wang P; Tang M; Liu K
    Cytotherapy; 2014 Nov; 16(11):1575-1583. PubMed ID: 25287603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autologous bone marrow stem cell transplantation attenuates hepatocyte apoptosis in a rat model of ex vivo liver resection and liver autotransplantation.
    Xu T; Wang X; Chen G; He Y; Bie P
    J Surg Res; 2013 Oct; 184(2):1102-8. PubMed ID: 23830366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosis.
    Kim JK; Park YN; Kim JS; Park MS; Paik YH; Seok JY; Chung YE; Kim HO; Kim KS; Ahn SH; Kim DY; Kim MJ; Lee KS; Chon CY; Kim SJ; Terai S; Sakaida I; Han KH
    Cell Transplant; 2010; 19(10):1237-46. PubMed ID: 20525430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibroblast growth factor 2 facilitates the differentiation of transplanted bone marrow cells into hepatocytes.
    Ishikawa T; Terai S; Urata Y; Marumoto Y; Aoyama K; Sakaida I; Murata T; Nishina H; Shinoda K; Uchimura S; Hamamoto Y; Okita K
    Cell Tissue Res; 2006 Feb; 323(2):221-31. PubMed ID: 16228231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autologous transplantation of bone marrow-derived mononuclear and CD133(+) cells in patients with decompensated cirrhosis.
    Nikeghbalian S; Pournasr B; Aghdami N; Rasekhi A; Geramizadeh B; Hosseini Asl SM; Ramzi M; Kakaei F; Namiri M; Malekzadeh R; Vosough Dizaj A; Malek-Hosseini SA; Baharvand H
    Arch Iran Med; 2011 Jan; 14(1):12-7. PubMed ID: 21194255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo differentiation of magnetically labeled mesenchymal stem cells into hepatocytes for cell therapy to repair damaged liver.
    Ju S; Teng GJ; Lu H; Jin J; Zhang Y; Zhang A; Ni Y
    Invest Radiol; 2010 Oct; 45(10):625-33. PubMed ID: 20808237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transplanted endothelial progenitor cells ameliorate carbon tetrachloride-induced liver cirrhosis in rats.
    Liu F; Liu ZD; Wu N; Cong X; Fei R; Chen HS; Wei L
    Liver Transpl; 2009 Sep; 15(9):1092-100. PubMed ID: 19718641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential therapeutic application of intravenous autologous bone marrow infusion in patients with alcoholic liver cirrhosis.
    Saito T; Okumoto K; Haga H; Nishise Y; Ishii R; Sato C; Watanabe H; Okada A; Ikeda M; Togashi H; Ishikawa T; Terai S; Sakaida I; Kawata S
    Stem Cells Dev; 2011 Sep; 20(9):1503-10. PubMed ID: 21417817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis.
    Chang YJ; Liu JW; Lin PC; Sun LY; Peng CW; Luo GH; Chen TM; Lee RP; Lin SZ; Harn HJ; Chiou TW
    Life Sci; 2009 Sep; 85(13-14):517-25. PubMed ID: 19686763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.